These findings align with other research, including evidence from preclinical studies showing that these drugs may reduce inflammation in the brain and enhance the brains ability to form and strengthen connections between its cells, improving how they communicate with one another
Some researchers have suggested that GLP-1 agonists might have potential neuroprotective effects and could theoretically improve mood in certain contexts, though this is based primarily on preclinical studies and limited human data
Importation may also breach customs and therapeutic goods rules
Although the visible adverse effects of GLP-1 receptor agonists nausea, vomiting, constipation and diarrhea are usually mild and limited to the gastrointestinal tract, other more unusual but serious complications have raised concerns, such as a possible increased risk of pancreatitis
GLP-1 medications may be worth discussing with your provider if you have PMOS and one or more of these patterns: Insulin resistance, prediabetes, type 2 diabetes, or elevated fasting insulin
: - ,